Starting JAK inhibitors in the Asian population based on real-world experience
14 Nov 2023
Dermatologists from Asia shared their clinical experience on the use of
Janus kinase (JAK) inhibitors in atopic dermatitis (AD) and discussed
approaches towards shared patient and doctor decision-making for
treatment with JAK inhibitors. Dr Mark Tang (Mount Alvernia Hospital,
Singapore) chaired the virtual meeting, which was attended by local
dermatologists.
Resources
Starting JAK inhibitors in the Asian population based on real-world experience
Starting JAK inhibitors in the Asian population based on real-world experience